For a second year, SSO is excited to collaborate with the San Antonio Breast Cancer Symposium (SABCS) to deliver a plenary lecture and an education session at SABCS’s virtual meeting. On Tuesday, December 8th, “De-escalation of Surgical Therapy: What Does the Data Support,” a pro/con issue-based discussion will be moderated by Eleftherios P. Mamounas, MD, MPH. The first topic in this discussion is “DCIS” and E. Shelley Hwang, MD, MPH will present the “Pro” side of the argument and Sarah McLaughlin, MD will present the “Con” side. The second topic is “Exceptional Responders to Neoadjuvant Chemotherapy.” Joerg Heil, MD, PhD, will present the “Pro” side of the debate and Monica Morrow, MD, will present the “Con” side.
Also on December 8th, the SSO/SABCS joint plenary lecture, “Local Regional Management Following Neoadjuvant Therapy: Minding the Knowledge Gaps,” presented by Elizabeth A. Mittendorf, MD, PhD, and “Is There a Future for Cooperative Group Trials?,” presented by Norman E. “Ned” Sharpless, MD will be conducted.
SABCS takes place virtually December 8 – 12, 2020. Visit the SABCS website for program information and to register.